BIOMAT Database Logo BIOMAT Database Logo

[Modern pathogenetic aspects of nephrolithiasis]. 1986

A Fabris, and V Ortalda, and A D'Angelo, and G Maschio

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007669 Kidney Calculi Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE. Kidney Stones,Renal Calculi,Nephrolith,Renal Calculus,Calculi, Kidney,Calculi, Renal,Calculus, Kidney,Calculus, Renal,Kidney Calculus,Kidney Stone,Stone, Kidney,Stones, Kidney
D010070 Oxalates Derivatives of OXALIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are derived from the ethanedioic acid structure. Oxalate,Ethanedioic Acids,Oxalic Acids,Acids, Ethanedioic,Acids, Oxalic
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[MODERN CLINICO-PATHOGENETIC ASPECTS OF INFECTIOUS DISEASES].
May 1964, Minerva medica,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[Modern pathogenetic, clinical & prophylactic aspects of fatigue].
November 1957, La Medicina del lavoro,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[The pathogenetic basis of nephrolithiasis].
January 1994, Minerva pediatrica,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[Modern aspects of the pathogenetic therapy of cardiogenic shock].
September 1980, Klinicheskaia meditsina,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[Modern aspects of pathogenetic treatment of sensorineural hearing loss].
January 2020, Vestnik otorinolaringologii,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[Modern pathogenetic aspects of development of cerebral chronic ischemia].
January 2015, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[Modern diagnostic and management aspects of citrate therapy for uric acid nephrolithiasis].
February 2016, Urologiia (Moscow, Russia : 1999),
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[The etiological and pathogenetic bases of nephrolithiasis].
January 1995, Urologiia i nefrologiia,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
Metabolic aspects of nephrolithiasis.
November 1986, Journal of the Tennessee Medical Association,
A Fabris, and V Ortalda, and A D'Angelo, and G Maschio
[Letter: Aspects of nephrolithiasis].
January 1974, Ugeskrift for laeger,
Copied contents to your clipboard!